Correlation Between Apex Biotechnology and CHC Healthcare

Can any of the company-specific risk be diversified away by investing in both Apex Biotechnology and CHC Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apex Biotechnology and CHC Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Apex Biotechnology Corp and CHC Healthcare Group, you can compare the effects of market volatilities on Apex Biotechnology and CHC Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apex Biotechnology with a short position of CHC Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apex Biotechnology and CHC Healthcare.

Diversification Opportunities for Apex Biotechnology and CHC Healthcare

0.53

Correlation Coefficient

Apex Biotechnology  CHC Healthcare

Very weak diversification

The 3 months correlation between Apex and CHC is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Apex Biotechnology Corp and CHC Healthcare Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHC Healthcare Group and Apex Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apex Biotechnology Corp are associated (or correlated) with CHC Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHC Healthcare Group has no effect on the direction of Apex Biotechnology i.e., Apex Biotechnology and CHC Healthcare go up and down completely randomly.

Pair Corralation between Apex Biotechnology and CHC Healthcare

Assuming the 90 days trading horizon Apex Biotechnology is expected to generate 1.87 times less return on investment than CHC Healthcare. But when comparing it to its historical volatility, Apex Biotechnology Corp is 2.54 times less risky than CHC Healthcare. It trades about 0.24 of its potential returns per unit of risk. CHC Healthcare Group is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  4,190  in CHC Healthcare Group on December 28, 2024 and sell it today you would earn a total of  1,090  from holding CHC Healthcare Group or generate 26.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Apex Biotechnology Corp  vs.  CHC Healthcare Group

Apex Biotechnology Corp

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Apex Biotechnology Corp are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Apex Biotechnology showed solid returns over the last few months and may actually be approaching a breakup point.

CHC Healthcare Group

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CHC Healthcare Group are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, CHC Healthcare showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Apex Biotechnology and CHC Healthcare

The main advantage of trading using opposite Apex Biotechnology and CHC Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apex Biotechnology position performs unexpectedly, CHC Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHC Healthcare will offset losses from the drop in CHC Healthcare's long position.

The idea behind Apex Biotechnology Corp and CHC Healthcare Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.